ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile Into CoreWeave as Tesla Buzz Grows

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers stepped up pressure on CRWV this week. CoreWeave's short interest jumped 3.66 percentage points in seven days to 23.7% of free float. That is the biggest weekly rise among US stocks with a market cap above $500 million.

TSLA is in focus today. Tesla reports Q3 2026 earnings on 21 October. German car registration data, a dataset ORTEX Alt Data measures as leading Tesla revenue by 43 days, is running 269% above Q3 2025 levels. Short interest in Tesla remains low at just 2.6% of free float, leaving bears with little ammunition.

WOLF carries the heaviest short load among larger names. Wolfspeed sits at 85.6% of free float sold short. Zero shares are available to borrow. That combination signals a crowded, illiquid short that could unwind fast.

CHWY is another name bears have circled. Chewy's SI stands at 89.2% of free float. Availability is 518%, so supply is not the constraint here. Shorts appear comfortable staying in the trade.

EVCM has the attention of short sellers too. EverCommerce carries a 96 ORTEX short score and a cost to borrow of 95%. Only 1.6% of short interest has shares available to borrow, making this one of the hardest stocks to short further.

A SpaceX-Tesla megamerger story is circulating on social media today. The news has an impact score of 12 out of 10 on ORTEX. With TSLA shorts already thin, any positive catalyst could catch bears offside quickly.

Stocks in this article

How this article was generated

Generated
21 Oct 2026, 20:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.